Pharma & Biotech

The launch of Quantum-Si's latest protein sequencing platform has captured market attention, but investors remain focused on whether this innovation...

Shares of Pulmonx Corp are experiencing significant upward momentum following a notably optimistic research note from D. Boral Capital. The...

All eyes are on Vir Biotechnology today as CEO Marianne De Backer takes the stage at the Morgan Stanley Healthcare...

Investor attention is firmly fixed on Akero Therapeutics today, fueled by a wave of positive analyst commentary and a significant...

Lexicon Pharmaceuticals finds itself at a pivotal moment. Following substantial progress within its drug development pipeline and notable stock price...

Shares of Allogene Therapeutics have demonstrated significant volatility, with a recent 3.6% gain on September 8th starkly contrasting a substantial...

Altimmune finds itself at a crossroads this week, presenting its investment case at the H.C. Wainwright Global Investment Conference while...

A significant regulatory development from the US Food and Drug Administration (FDA) is poised to fast-track Philip Morris International's strategic...

Iovance Biotherapeutics finds itself navigating a complex landscape where significant regulatory achievements contrast sharply with persistent financial headwinds. The company's...

Shares of Laboratory Corp. of America are attracting significant investor attention following a series of positive developments. The company recently...